The human respiratory tract pathogen M. pneumoniae is one of the best characterized minimal bacterium. Until now, two main groups of clinical isolates of this bacterium have been described (types 1 an
Implementation of conjugate technology revolutionized the ability to effectively elicit long-lasting immune responses to bacterial capsular polysaccharides, and significantly reduced the burden of inv